NASDAQ:TRVI | Total Assets | Trevi Therapeutics, Inc.

Complete source-backed total assets history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Total Assets

DateTotal assetsCurrent assetsCash and equivalentsCurrent securitiesReceivablesInventoryProperty, plant and equipmentOther noncurrent assets
2026-06-30$330.52M$325.71M$54.3M$264.57M$336,000.00$3.94M
2026-03-31$179.61M$176.12M$19.41M$152.37M$265,000.00$2.61M
2025-12-31$193.44M$191.66M$18.91M$169.35M$178,000.00$928,000.00
2025-09-30$199.36M$198.3M$56.87M$138.06M$213,000.00$103,000.00
2025-06-30$208.34M$207.23M$117.06M$86.83M$239,000.00$68,000.00
2025-03-31$107M$105.62M$19.37M$83.88M$277,000.00$241,000.00
2024-12-31$110.9M$109.43M$34.1M$73.53M$157,000.00$243,000.00
2024-09-30$68.91M$67.34M$16.05M$49.44M$174,000.00$256,000.00
2024-06-30$73.81M$72.13M$12.96M$56.53M$198,000.00$273,000.00
2024-03-31$78.56M$76.77M$13.81M$59.01M$204,000.00$311,000.00
2023-12-31$89.4M$87.55M$32.4M$50.57M$216,000.00$297,000.00
2023-09-30$95.9M$93.95M$25.97M$62.9M$238,000.00$297,000.00
2023-06-30$100.98M$99.21M$13.75M$80.4M$225,000.00$68,000.00
2023-03-31$116.21M$114.2M$11.65M$99.61M$245,000.00$225,000.00
2022-12-31$123.02M$122.62M$12.59M$107.92M$170,000.00$205,000.00
2022-09-30$128.36M$127.32M$66.57M$59.03M$68,000.00$922,000.00
2022-06-30$81.41M$79.89M$24.7M$53.16M$34,000.00$413,000.00
2022-03-31$30.39M$29.84M$29.11M$42,000.00$398,000.00
2021-12-31$38.48M$37.96M$36.83M$53,000.00$334,000.00
2021-09-30$31.6M$30.71M$29.32M$66,000.00
2021-06-30$39.15M$38.48M$36.43M$78,000.00
2021-03-31$42.86M$42.16M$41.57M$91,000.00
2020-12-31$47.13M$46.27M$45M$103,000.00$532,000.00
2020-09-30$55.88M$55.21M$53.29M$110,000.00
2020-06-30$47.01M$46.34M$44.18M$109,000.00
2020-03-31$54.24M$53.82M$52.64M$107,000.00
2019-12-31$60M$59.55M$57.31M$118,000.00
2019-09-30$66.02M$65.54M$63.52M$128,000.00
2019-06-30$75.12M$74.61M$71.39M$139,000.00
2019-03-31$17.19M$14.76M$12.95M$149,000.00
2018-12-31$10.53M$8.82M$7.2M$149,000.00
2018-09-30$13.53M
2018-06-30$7.06M
2018-03-31$15.96M
2017-12-31$22.02M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.